­
­
­
­

Inventi Impact: Urology & Nephrology

Articles

  • Inventi:hun/33299/20
    Efficacy and Safety of Transurethral Split of Prostate for Benign Prostatic Hyperplasia: A Meta Analysis
    Research 2021 : January - March
    Yiyu Huang, Jiaxin LI, Shan Yang, Daozhang Yuan, Shusheng Wang

    Background: Transurethral resection of the prostate (TURP) is the first choice for the treatment of benign prostatic\nhyperplasia. However, Transurethral split of prostate (TUSP) also seems to have clear clinical efficacy and clinical\npromotion value. To better clarify the potential and limitations of this treatment of prostate hyperplasia. This study\nobjectively evaluated the clinical efficacy and safety of TUSP.\nMethods: The Pubmed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Database for\nChinese Technical Periodicals (VIP), Wanfang (Wanfang data), and SinoMed databases were searched for relevant\nstudies. We then used Revman Manager 5.3 to perform a meta-analysis of all randomized controlled trials that\nevaluated the efficacy and safety of TUSP versus....................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Huang, Yiyu, et al.\n\"Efficacy and safety of transurethral split of prostate for\nbenign prostatic hyperplasia: a meta-analysis.\" BMC\nurology 20.1 (2020): 1-11.\nhttps://doi.org/10.1186/s12894-020-00704-4\nhttp://creativecommons.org/licenses/by/4.0/\nSome formatting elements, header, footer, logos, dates and\npagination were modified while adapting this article.
    Download Full Text